CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.

CRL | NYSE

Overview

Corporate Details

ISIN(s):: US1598641074
LEI:
Country:: United States of America
Address:: 251 BALLARDVALE ST, 1887 WILMINGTON
Website:: https://www.criver.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Charles River Laboratories International, Inc., founded in 1947, is a leading global contract research organization (CRO). The company provides essential products and services to support the entire drug discovery and development continuum for the pharmaceutical, biotechnology, and medical device industries. Its offerings span from early-stage research and discovery to non-clinical development, safety assessment, and manufacturing solutions. A key component of its business is the provision of a wide range of research models for laboratory testing. By partnering with clients worldwide, Charles River aims to accelerate the development of novel therapies, ensuring they are brought to market safely and efficiently.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Hyundai ADM Bio lnc. Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.	South Korea	187660
HYUNDAI BIOSCIENCE CO., LTD. Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.	South Korea	048410
iBio, Inc. AI-powered biotech developing antibody therapeutics for cardiometabolic diseases and obesity.	United States of America	IBIO
Ibotta, Inc. A performance marketing platform offering cash-back rewards to consumers from CPG brands.	United States of America	IBTA
ICON PLC Global CRO providing outsourced development & commercialization for pharma, biotech & device firms.	United States of America	ICLR
IDEAYA Biosciences, Inc. Clinical-stage firm developing precision cancer therapies via synthetic lethality.	United States of America	IDYA
IMGT Corporation Limited Develops a drug delivery platform using ultrasound and nanotech for oncology.	South Korea	456570
IMMERSION CORP Licenses patented haptic feedback technology for mobile, gaming, and automotive interfaces.	United States of America	IMMR
IMMUNIC, INC. Developing oral small molecule therapies for chronic inflammatory and autoimmune diseases.	United States of America	IMUX
IMMUTEP Ltd Developing LAG-3-based immunotherapies for cancer and autoimmune diseases.	United States of America	IMMP